Stockreport

Genprex Provides Clinical and Corporate Update for Second Quarter 2018

Genprex, Inc.  (GNPX) 
Last genprex, inc. earnings: 11/14 12:08 pm Check Earnings Report
PDF AUSTIN, Texas--(BUSINESS WIRE)-- Genprex, Inc. (NASDAQ:GNPX), a clinical stage gene therapy company developing a new approach to treating cancer based [Read more]